Malignant Liver Tumors: Current and Emerging Therapies: Third Edition
Novel Therapies Targeted at Signal Transduction in Liver Tumors
Publication
, Chapter
Huitzil-Melendez, FD; Abou-Alfa, GK; Morse, MA
December 9, 2009
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Huitzil-Melendez, F. D., Abou-Alfa, G. K., & Morse, M. A. (2009). Novel Therapies Targeted at Signal Transduction in Liver Tumors. In Malignant Liver Tumors: Current and Emerging Therapies: Third Edition (pp. 382–392). https://doi.org/10.1002/9781444317053.ch32
Huitzil-Melendez, F. D., G. K. Abou-Alfa, and M. A. Morse. “Novel Therapies Targeted at Signal Transduction in Liver Tumors.” In Malignant Liver Tumors: Current and Emerging Therapies: Third Edition, 382–92, 2009. https://doi.org/10.1002/9781444317053.ch32.
Huitzil-Melendez FD, Abou-Alfa GK, Morse MA. Novel Therapies Targeted at Signal Transduction in Liver Tumors. In: Malignant Liver Tumors: Current and Emerging Therapies: Third Edition. 2009. p. 382–92.
Huitzil-Melendez, F. D., et al. “Novel Therapies Targeted at Signal Transduction in Liver Tumors.” Malignant Liver Tumors: Current and Emerging Therapies: Third Edition, 2009, pp. 382–92. Scopus, doi:10.1002/9781444317053.ch32.
Huitzil-Melendez FD, Abou-Alfa GK, Morse MA. Novel Therapies Targeted at Signal Transduction in Liver Tumors. Malignant Liver Tumors: Current and Emerging Therapies: Third Edition. 2009. p. 382–392.